MYP_011904
Basic Information
NTW (S-S)[F1A]
Antimicrobial
Antiviral
Antiviral Anti-Hepatitis virus Anti-HCV
Standard
13 amino acids
C59H83N17O16S2
Standard
Sequence
ACAPWGNTWCGGK
Physicochemical Analysis
1350.52 Da
8.10
0.78
0.56
0.0596
-0.32
0.18
0.21
25.99
15.38
0.1538
11000.00
11125.00
The radar chart summarizes major physicochemical dimensions for quick comparison, while exact numerical values remain listed on the left.
Residue Composition
Amino Acid Composition
Chemical Descriptors
524.65
-5.65
20.0
19.0
37.0
94.0
5.0
13.0
Structural Visualization
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber in the current view mode. Use the buttons to zoom.
2D CHEMICAL STRUCTURE
Drag to move
Drag to move. Use the buttons to zoom.
Experimental Records
RECORD: Rec_0091321 VERIFIED: YES
Provenance & Taxonomy
synthetic construct [Synthetic]
Synthetic peptide
32630
Structure & Mods
disulfide-constrained cyclic peptide [Cyclic]
canonical L-amino-acid peptide [L]
None
None
2-10
Disulfide bond between Cys2 and Cys10
Bio-Activity Profile
Antiviral Anti-HCV
Hepatitis C virus(HCV)
200 μM
IC50
Mammalian: 4.4 h; Yeast: >20 h; E. coli: >10 h
RECORD: Rec_0342311 VERIFIED: YES
Provenance & Taxonomy
synthetic construct [Synthetic]
32630
Structure & Mods
cyclic/stapled peptide [Cyclic]
canonical L-amino-acid peptide [L]
None
None
2-10
Bio-Activity Profile
Antimicrobial Antiviral
RECORD: Rec_0358793 VERIFIED: YES
Provenance & Taxonomy
synthetic construct [Synthetic]
32630
Structure & Mods
cyclic/stapled peptide [Cyclic]
canonical L-amino-acid peptide [L]
None
None
2-10
Bio-Activity Profile
Antimicrobial Antiviral
Hepatitis C virus(HCV):inhibition of polymerase activity
200 μM
IC50